"The shifts in the financial markets, international forces and the 2008 election will have enormous impact on the future of new technology in healthcare. The Medical Innovation Summit provides unrivaled insights, exceptional networking and actionable takeaways for anyone who cares about medical innovation."
- Tim Ring, CR Bard
CEOS of GE, Johnson & Johnson, Eli Lilly, Abbott, AstraZeneca, Amgen, Boston
Scientific, 3M, Medtronic and Edwards Lifesciences; partners from top venture
firms, heads of Government agencies and top clinicians.
IN MEMORIAM
Andrew C. Novick, MD
1948 - 2008
|
| Cleveland, Ohio | InterContinental Hotel & Bank of America Conference Center |
Presenters for “Top 10” Medical Innovations for 2009
Gene Barnett, MD, Professor & Director, Neurological Institute
Dr. Barnett is responsible for establishing the multidisciplinary
Brain Tumor and Neuro-oncology Center of the Cleveland
Clinic Neurological Institute. As its Director, he oversees and
coordinates the clinical and research direction of the brain
tumor. Dr. Barnett is recognized as a leader in the area of
surgical navigation and its application with minimally invasive
surgery. These accomplishments have helped lead to The Clinic’s CAMIS (computer-assisted minimally invasive
surgery) project, a multi-million dollar effort supported by
federal and industry funding aimed at improved surgical
patient care at reduced costs through the use of advanced
computer and minimally invasive surgery techniques. He
is currently working on development of advanced surgical
navigation systems, laser interstitial thermal therapy and
neurosurgical robotics.
Ernest Borden, MD, Deputy Director, Taussig Cancer Institute
Ernest C. Borden obtained his medical degree from Duke
University and joined Cleveland Clinic in 1998 to direct the
Center for Cancer Drug Discovery and Development. In 2005,
the 5 laboratories in the Case Western Reserve Cleveland
Clinic College of Medicine were integrated to form the Center
for Hematology and Oncology Molecular Therapeutics (CHOMT) with Dr. Borden named as Director. He is also a
staff member in the Department of Solid Tumor Oncology
and a Professor in Cancer Biology in the Lerner Research
Institute. Dr. Borden has an international reputation for
research and treatment of melanomas and sarcomas and has
been listed in Best Doctors of America for the past 10 years.
Mihir Desai, MD, Director, Glickman Urological and Kidney Institute
Dr. Desai is Director of the Stevan B. Streem Center for
Endourology at the Glickman Urological and Kidney Institute
of Cleveland Clinic, and Associate Professor of Surgery at the
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr Desai’s clinical and research interests
include stone disease, upper-urinary-tract obstruction, and
laparoscopic and robotic surgery of the kidney, adrenal,
prostate and bladder.
Jennifer Hunt, MD, Section Head, Department of Anatomic Pathology
Dr. Hunt started her career at the University of Pittsburgh
Medical Center practicing head and neck and endocrine
pathology, and running the active and innovative Molecular
Anatomic Pathology laboratory at UPMC. In 2006, she was
appointed as the Director of Surgical Pathology at Cleveland
Clinic and Associate Professor at the Lerner College of Medicine of Case Western Reserve University. Dr. Hunt’s
research interests have focused on head and neck and
endocrine tumors, with an emphasis on developing
molecular approaches to improving tumor diagnosis and
assessment of prognosis.
Eric Jelovsek, MD, OB/GYN and Women’s Health Institute
Dr. Eric Jelovsek is an Assistant Professor of Surgery in the
Section of Urogynecology and Female Pelvic Reconstructive
Surgery, Department of Obstetrics and Gynecology,
Cleveland Clinic Lerner College of Medicine of Case Western
Reserve University. He is the residency site director in OB/
GYN and Director of Surgical Education. He completed his residency in Obstetrics and Gynecology at Duke
University in 2003 and completed a fellowship in
Urogynecology and Female Pelvic Medicine at the Cleveland
Clinic. His research interests include: surgical education,
bowel and anorectal disorders in women, and quality of
life in women suffering from both pelvic floor disorders.
Samir Kapadia, MD, Heart and Vascular Institute
Samir Kapadia, MD, is an interventional cardiologist in the
Cleveland Clinic Department of Cardiovascular Medicine. He is
board-certified in internal medicine, cardiology and interventional
cardiology. As an interventional cardiologist, Dr. Kapadia has a special interest in coronary, structural heart
disease-related cardiac interventions as well as carotid
and peripheral interventions.
Richard Lang, MD, Vice Chairman, Wellness Institute
Richard S. Lang, MD, MPH, Vice Chairman of the Wellness
Institute and Head of the Section of Preventive Medicine, is
a staff physician in the Executive Health Program. He joined
Cleveland Clinic in 1986. Dr. Lang is certified by the American
Board of Internal Medicine and the American Board of
Preventive Medicine in occupational medicine, and is a fellow of both the American College of Physicians and the
American College of Preventive Medicine. He also is qualified
as a Federal Aviation Administration medical examiner
to perform Class I, II and III medical certification examinations
of pilots.
Tomislav Mihaljevic, MD, Staff Surgeon, Heart and Vascular Institute
Dr. Mihaljevic is part of a multi-disciplinary team of health
care providers who specialize in thoracic and cardiovascular
surgery and transplant medicine. His interests include minimally
invasive cardiac surgery, image-guided cardiac surgery,
robotics in cardiac surgery and mitral and aortic valve repair and replacement. Prior to his Cleveland Clinic appointment,
Dr. Mihaljevic was the Director of Cardiac Surgery Research
and an Associate Surgeon in the Division of Cardiac Surgery
at Brigham & Women’s Hospital in Boston.
Marc Penn, MD, PhD, Staff Cardiologist, Heart & Vascular Institute
Dr. Penn is a staff cardiologist in the Department of
Cardiovascular Medicine. Dr. Penn is board certified in Internal
Medicine and Cardiovascular Medicine. He has a special interest
in myocardial ischemia, vascular biology, cardiac critical
care and stem cell and gene therapy for the regeneration and recovery of myocardial function. Dr. Penn has developed
drug delivery systems for the treatment of cardiovascular
disease, including studies to optimize gene therapy and
stem cell therapy for the regeneration of myocardial tissue
from which several patents are pending.
James Young, MD, Chairman, Academic Department of Medicine
Dr. Young is Professor and Chairman, Academic Department of
Medicine, Cleveland Clinic Lerner College of Medicine of Case
Western Reserve University and Chairman, Endocrinology
and Metabolism Institute. He is also Physician Director
of Institutional Relations and Development and a Medical
Director of the Kaufman Center for Heart Failure. He holds
the George and Linda Kaufman Chair and is the Study Chairman of the NIH, FDA, and CMS Interagency Registry
for Mechanical Circulatory Assist Support INTERMACS).
He has a joint appointment to the Multi-organ Transplant
Center. Dr. Young is certified as a Diplomat of the American
Board of Internal Medicine as well as the subspecialty of
Cardiovascular Disease and holds medical licensure from the
states of California, Illinois, Ohio, Pennsylvania and Texas.
|
|
